IL7R and neoplasm: Stimulation of the memory T-cell compartments appears to be of importance for the reported anti-tumor activities of IL-7R agonists, either administered to animals or patients; or treatment of engineered T-cells undergoing ex vivo expansion prior to transfer to patients.